ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 2604

$753K Total Retail Price of All Prescriptions

Rank: 58 out of 2604

306 Patients Receiving at Least One Drug in Part D
36%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 306 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

62% of this provider’s 306 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 4,653 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,531 370 S3 1 1
OMEPRAZOLE 543 171 2 5
SIMVASTATIN 472 204 3 2
CARISOPRODOL 443 68 R 4 54
LISINOPRIL 391 175 5 3
AMLODIPINE BESYLATE 297 168 6 6
PROAIR HFA 295 93 7 27
POTASSIUM CHLORIDE 295 158 7 16
FUROSEMIDE 290 138 9 8
METOPROLOL TARTRATE 220 123 10 9
IBUPROFEN 195 48 11 32
METFORMIN HCL 185 74 12 7
CYCLOBENZAPRINE HCL 176 29 R 13 43
ZOLPIDEM TARTRATE 174 25 14 21
GABAPENTIN 169 26 15 12
LEVOTHYROXINE SODIUM 167 73 16 4
OXYCODONE HCL 151 40 S2 17 61
RANITIDINE HCL 139 39 18 25
GEMFIBROZIL 138 20 19 87
HYDROCHLOROTHIAZIDE 135 92 20 10
CLOPIDOGREL 131 61 21 39
METHOCARBAMOL 127 26 R 22 153
ADVAIR DISKUS 126 34 23 41
ALLOPURINOL 119 50 24 35
TRAZODONE HCL 111 56 25 46
CLONIDINE HCL 107 48 26 56
FLUTICASONE PROPIONATE 105 30 27 31
SERTRALINE HCL 94 39 28 23
GLIPIZIDE 92 49 29 51
ACETAMINOPHEN-CODEINE 90 54 S3 30 60
AZITHROMYCIN 89 35 31 33
MELOXICAM 89 32 31 36
ISOSORBIDE MONONITRATE ER 83 52 33 38
HYDROMORPHONE HCL 79 12 S2 34 175
OPANA ER 77 18 S2 35 230
COMBIVENT 73 32 36 169
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 17 36 22
TAMSULOSIN HCL 72 40 38 30
PLAVIX 72 38 38 75
FENTANYL 68 0 S2 40 48
NEXIUM 67 26 41 53
LANTUS SOLOSTAR 64 18 42 84
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 19 43 91
SYMBICORT 62 0 44 105
LIDODERM 61 23 45 80
MECLIZINE HCL 57 32 46 155
VENTOLIN HFA 57 0 46 63
SPIRONOLACTONE 56 15 48 78
CITALOPRAM HBR 55 42 49 18
DONEPEZIL HCL 55 50 49 28
WARFARIN SODIUM 55 28 49 13
CYMBALTA 53 12 52 44
CARVEDILOL 53 23 52 26
SINGULAIR 52 24 54 120
NIFEDIPINE ER 50 38 55 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.